Paul R Edick Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Edick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul R Edick. Paul R Edick is a Director in PDL BIOPHARMA, INC. ($PDLI) and a Director in NEWLINK GENETICS CORP ($NLNK) and a See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and a Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Director in Milestone Pharmaceuticals Inc. ($MIST) and a Director in Neos Therapeutics, Inc. ($NEOS) and a Director in Iterum Therapeutics plc ($ITRM).
Address: C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR., SUITE 5100 AMES 50010 IA
Companies in which Paul R Edick is an Insider
Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 31,390 shares
Latest Transaction: May 29 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 7,906 shares
Current Value: $108,075
Latest Transaction: May 16 2017
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Milestone Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 05 2016
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul R Edick: Director
Holdings: 214,563 shares
Current Value: $474,184
Latest Transaction: Jun 12 2018
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sucampo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 14,930 shares
Current Value: $169,456
Latest Transaction: Jun 05 2017
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XERIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: See Remarks
Holdings: 636,134 shares
Latest Transaction: Feb 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul R Edick
Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | A | 5.08 | 400,000 | 2,032,000 | 400,000 | |
| Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 225,000 | 0 | 636,134 | 411.1 K to 636.1 K (+54.73 %) |
| Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
| Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
| Jun 08 2020 | MIST | Milestone Pharmace ... | Edick Paul R | Director | Option Exercise | A | 3.74 | 15,000 | 56,100 | 15,000 | |
| May 11 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 3.00 | 33,000 | 99,000 | 401,134 | 368.1 K to 401.1 K (+8.96 %) |
| Mar 02 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 185,000 | 0 | 368,134 | 183.1 K to 368.1 K (+101.02 %) |